Current Ratio of Whitehawk Therapeutics, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Whitehawk Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Whitehawk Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 1330%, a 182% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Whitehawk Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1330% +858% +182% 30 Sep 2025
Q2 2025 1020% +510% +100% 30 Jun 2025
Q1 2025 690% +57% +9% 31 Mar 2025
Q4 2024 446% -284% -39% 31 Dec 2024
Q3 2024 472% -417% -47% 30 Sep 2024
Q2 2024 509% -498% -49% 30 Jun 2024
Q1 2024 633% -350% -36% 31 Mar 2024
Q4 2023 731% -305% -29% 31 Dec 2023
Q3 2023 888% -161% -15% 30 Sep 2023
Q2 2023 1007% -118% -10% 30 Jun 2023
Q1 2023 983% -216% -18% 31 Mar 2023
Q4 2022 1035% -221% -18% 31 Dec 2022
Q3 2022 1050% +486% +86% 30 Sep 2022
Q2 2022 1125% +728% +183% 30 Jun 2022
Q1 2022 1199% +790% +193% 31 Mar 2022
Q4 2021 1256% +867% +223% 31 Dec 2021
Q3 2021 564% -901% -62% 30 Sep 2021
Q2 2021 397% -904% -69% 30 Jun 2021
Q1 2021 409% -869% -68% 31 Mar 2021
Q4 2020 389% -908% -70% 31 Dec 2020
Q3 2020 1465% +186% +15% 30 Sep 2020
Q2 2020 1301% -125% -8.8% 30 Jun 2020
Q1 2020 1278% +535% +72% 31 Mar 2020
Q4 2019 1297% +662% +104% 31 Dec 2019
Q3 2019 1278% +740% +137% 30 Sep 2019
Q2 2019 1427% +1010% +243% 30 Jun 2019
Q1 2019 744% -37% -4.7% 31 Mar 2019
Q4 2018 635% -388% -38% 31 Dec 2018
Q3 2018 539% +117% +28% 30 Sep 2018
Q2 2018 416% 30 Jun 2018
Q1 2018 781% 31 Mar 2018
Q4 2017 1022% 31 Dec 2017
Q3 2017 421% 30 Sep 2017
Q1 2013 9.6%* -8.6% 31 Mar 2013
Q4 2012 15%* 31 Dec 2012
Q3 2012 16%* 30 Sep 2012
Q2 2012 17%* 30 Jun 2012
Q1 2012 18%* 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.